Relmada Therapeutics
RLMD
#7932
Rank
ยฃ0.22 B
Marketcap
ยฃ3.12
Share price
-5.20%
Change (1 day)
749.58%
Change (1 year)

Revenue for Relmada Therapeutics (RLMD)

Revenue in 2025 (TTM): N/A

In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Relmada Therapeutics from 2012 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) N/A
2024 N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A
2017 N/A
2016 N/A
2015 N/A
2013 ยฃ0 M-53.09%
2012 ยฃ0 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Taro Pharmaceutical
TARO
ยฃ0.45 BN/A๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Cytokinetics
CYTK
ยฃ65.03 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA